Benjamin Hickey

Affiliations

  • President, Rayzebio Org. at Bristol Myers Squibb Co (BMY), 2024-03-12
  • Evp, Chief Commercial Officer at Mirati Therapeutics Inc. (MRTX), 2024-01-24
  • at Mural Oncology Plc (MURA), 2023-12-18
  • Director at Surface Oncology Inc. (SURF), 2022-06-11
  • Svp, Chief Commerical Officer at Halozyme Therapeutics Inc. (HALO), 2019-10-01
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRTX $59.02 631 Officer 117,028 2024-01-16 Filing
MRTX $59.02 966 Officer 117,659 2024-01-16 Filing
MRTX $58.92 2,090 Officer 118,625 2024-01-08 Filing
MRTX $56.67 2,220 Officer 103,694 2023-12-13 Filing
MRTX $42.38 619 47,223 2023-01-17 Filing